Company intelligence / Profile preview

Central China International Capital

Ownership: Private
Employees: ~10000
Development stage: Other

Overview

CICC is one of China's leading full-service investment banks with global reach. Its private equity division, CICC Capital, manages significant funds including those focused on biomedicine and biologics investments but does not itself conduct clinical research or drug development.

Industry: Investors

Partnerships

Acts as financial advisor/investor to firms in healthcare/biotech sector through its PE activities

Beyond the preview

Go deeper on Central China International Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central China International Capital.

Explore the full profile